Richard W. Rew II

Board Director

Vice-Président Senior, Conseiller Juridique et Secrétaire

Luminex Corp IsoPlexis Corp Tabula Rasa HealthCare, Inc.AdaptHealth Corp.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€78k

▼ Sales (0 ops.)

—

Latest filing published 27 Feb 2026 for AdaptHealth Corp., €38k. Read the official filing

Filing timeline

BuySale

Richard W. Rew II

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Richard W. Rew II: trading record in brief

This profile gathers the share dealings of Richard W. Rew II across 4 companies, led by AdaptHealth Corp., IsoPlexis Corp and Tabula Rasa HealthCare, Inc. Over a trading history stretching from 14 July 2021 to 26 February 2026, the count stands at 8 filings.

The open-market record is one-sided, with 2 purchases worth €78k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants. 2026 to date brings 1 purchase and no sales.

The newest entry dates from 27 February 2026: an open-market purchase of €38k, in AdaptHealth Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.